Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Introductory remarks

Luigi F Agnati1, Kjell Fuxe

  • 1Section of Physiology, Department of Biomedical Sciences, University of Modena and Reggio Emilia, 41100 Modena, Italy. agnati@tin.it

Journal of Molecular Neuroscience : MN
|July 14, 2005
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual Pathways Coupled to Oxytocin Molecular Signals in Cultured Astrocytes.

Cells·2026
Same author

The 3,4-methylenedioxymethamphetamine (MDMA) reduces prosocial behavior in the social preference test in male and female rats.

Pharmacology, biochemistry, and behavior·2025
Same author

Intracerebroventricular knockdown of NPY1R disrupts NPY1R-GALR2/TrkB heteroreceptor complexes without affecting neuroplasticity or depressive-like behaviour.

Journal of psychopharmacology (Oxford, England)·2025
Same author

Reducing stress and alcohol-related behaviors by targeting D1-CRHR1 receptor interactions in the amygdala.

Frontiers in pharmacology·2025
Same author

Interaction Between Oxytocin and Dopamine Signaling: Focus on the Striatum.

International journal of molecular sciences·2025
Same author

Peripheral expression of NPY1R-based heteroreceptor complexes reflects hippocampal neuroimmune status: Novel biomarkers for early Alzheimer's disease detection.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025